Molecule Information
General Information of the Molecule (ID: Mol04290)
| Name |
Outer membrane protein A (OmpA)
,Escherichia coli
|
||||
|---|---|---|---|---|---|
| Synonyms |
Outer membrane protein A (OmpA)
Click to Show/Hide
|
||||
| Molecule Type |
Protein
|
||||
| Click to Show/Hide the Complete Species Lineage | |||||
Type(s) of Resistant Mechanism of This Molecule
Drug Resistance Data Categorized by Drug
Approved Drug(s)
9 drug(s) in total
| Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
|
|
||||
| Disease Class: Tuberculosis [ICD-11: 1B10.0] | [1] | |||
| Resistant Disease | Tuberculosis [ICD-11: 1B10.0] | |||
| Resistant Drug | Amikacin | |||
| Molecule Alteration | Expressiom | Down-regulation |
||
| Experimental Note | Revealed Based on the Cell Line Data | |||
| In Vitro Model | Mycobacterium tuberculosis | 1773 | ||
| Experiment for Drug Resistance |
MIC assay | |||
| Mechanism Description | These results support the model that the roles of OmpA as a porin protein overexpressing in mycobacteria can increase the hydrophilic ability of the cell wall which can facilitate the streptomycin uptakes and increase the mycobacteria's sensitivity to aminoglycosides. | |||
| Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
|
|
||||
| Disease Class: Tuberculosis [ICD-11: 1B10.0] | [1] | |||
| Resistant Disease | Tuberculosis [ICD-11: 1B10.0] | |||
| Resistant Drug | Ethambutol | |||
| Molecule Alteration | Expressiom | Down-regulation |
||
| Experimental Note | Revealed Based on the Cell Line Data | |||
| In Vitro Model | Mycobacterium tuberculosis | 1773 | ||
| Experiment for Drug Resistance |
MIC assay | |||
| Mechanism Description | These results support the model that the roles of OmpA as a porin protein overexpressing in mycobacteria can increase the hydrophilic ability of the cell wall which can facilitate the streptomycin uptakes and increase the mycobacteria's sensitivity to aminoglycosides. | |||
| Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
|
|
||||
| Disease Class: Tuberculosis [ICD-11: 1B10.0] | [1] | |||
| Resistant Disease | Tuberculosis [ICD-11: 1B10.0] | |||
| Resistant Drug | Gentamicin | |||
| Molecule Alteration | Expressiom | Down-regulation |
||
| Experimental Note | Revealed Based on the Cell Line Data | |||
| In Vitro Model | Mycobacterium tuberculosis | 1773 | ||
| Experiment for Drug Resistance |
MIC assay | |||
| Mechanism Description | These results support the model that the roles of OmpA as a porin protein overexpressing in mycobacteria can increase the hydrophilic ability of the cell wall which can facilitate the streptomycin uptakes and increase the mycobacteria's sensitivity to aminoglycosides. | |||
| Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
|
|
||||
| Disease Class: Tuberculosis [ICD-11: 1B10.0] | [1] | |||
| Resistant Disease | Tuberculosis [ICD-11: 1B10.0] | |||
| Resistant Drug | Isoniazid | |||
| Molecule Alteration | Expressiom | D96D |
||
| Experimental Note | Revealed Based on the Cell Line Data | |||
| In Vitro Model | Mycobacterium tuberculosis | 1773 | ||
| Experiment for Drug Resistance |
MIC assay | |||
| Mechanism Description | These results support the model that the roles of OmpA as a porin protein overexpressing in mycobacteria can increase the hydrophilic ability of the cell wall which can facilitate the streptomycin uptakes and increase the mycobacteria's sensitivity to aminoglycosides. | |||
| Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
|
|
||||
| Disease Class: Tuberculosis [ICD-11: 1B10.0] | [1] | |||
| Resistant Disease | Tuberculosis [ICD-11: 1B10.0] | |||
| Resistant Drug | Ofloxacin | |||
| Molecule Alteration | Expressiom | D1194A+R1181K+D1194G |
||
| Experimental Note | Revealed Based on the Cell Line Data | |||
| In Vitro Model | Mycobacterium tuberculosis | 1773 | ||
| Experiment for Drug Resistance |
MIC assay | |||
| Mechanism Description | These results support the model that the roles of OmpA as a porin protein overexpressing in mycobacteria can increase the hydrophilic ability of the cell wall which can facilitate the streptomycin uptakes and increase the mycobacteria's sensitivity to aminoglycosides. | |||
| Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
|
|
||||
| Disease Class: Tuberculosis [ICD-11: 1B10.0] | [1] | |||
| Resistant Disease | Tuberculosis [ICD-11: 1B10.0] | |||
| Resistant Drug | Rifabutin | |||
| Molecule Alteration | Expressiom | D538G+Y537S+Y537N+E380Q |
||
| Experimental Note | Revealed Based on the Cell Line Data | |||
| In Vitro Model | Mycobacterium tuberculosis | 1773 | ||
| Experiment for Drug Resistance |
MIC assay | |||
| Mechanism Description | These results support the model that the roles of OmpA as a porin protein overexpressing in mycobacteria can increase the hydrophilic ability of the cell wall which can facilitate the streptomycin uptakes and increase the mycobacteria's sensitivity to aminoglycosides. | |||
| Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
|
|
||||
| Disease Class: Tuberculosis [ICD-11: 1B10.0] | [1] | |||
| Resistant Disease | Tuberculosis [ICD-11: 1B10.0] | |||
| Resistant Drug | Rifampin | |||
| Molecule Alteration | Expressiom | Down-regulation |
||
| Experimental Note | Revealed Based on the Cell Line Data | |||
| In Vitro Model | Mycobacterium tuberculosis | 1773 | ||
| Experiment for Drug Resistance |
MIC assay | |||
| Mechanism Description | These results support the model that the roles of OmpA as a porin protein overexpressing in mycobacteria can increase the hydrophilic ability of the cell wall which can facilitate the streptomycin uptakes and increase the mycobacteria's sensitivity to aminoglycosides. | |||
| Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
|
|
||||
| Disease Class: Tuberculosis [ICD-11: 1B10.0] | [1] | |||
| Resistant Disease | Tuberculosis [ICD-11: 1B10.0] | |||
| Resistant Drug | Rifapentine | |||
| Molecule Alteration | Expressiom | Down-regulation |
||
| Experimental Note | Revealed Based on the Cell Line Data | |||
| In Vitro Model | Mycobacterium tuberculosis | 1773 | ||
| Experiment for Drug Resistance |
MIC assay | |||
| Mechanism Description | These results support the model that the roles of OmpA as a porin protein overexpressing in mycobacteria can increase the hydrophilic ability of the cell wall which can facilitate the streptomycin uptakes and increase the mycobacteria's sensitivity to aminoglycosides. | |||
| Drug Sensitivity Data Categorized by Their Corresponding Mechanisms | ||||
|
|
||||
| Disease Class: Tuberculosis [ICD-11: 1B10.0] | [1] | |||
| Sensitive Disease | Tuberculosis [ICD-11: 1B10.0] | |||
| Sensitive Drug | Streptomycin | |||
| Molecule Alteration | Expressiom | Down-regulation |
||
| Experimental Note | Revealed Based on the Cell Line Data | |||
| In Vitro Model | Mycobacterium tuberculosis | 1773 | ||
| Experiment for Drug Resistance |
MIC assay | |||
| Mechanism Description | These results support the model that the roles of OmpA as a porin protein overexpressing in mycobacteria can increase the hydrophilic ability of the cell wall which can facilitate the streptomycin uptakes and increase the mycobacteria's sensitivity to aminoglycosides. | |||
Investigative Drug(s)
1 drug(s) in total
| Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
|
|
||||
| Disease Class: Tuberculosis [ICD-11: 1B10.0] | [1] | |||
| Resistant Disease | Tuberculosis [ICD-11: 1B10.0] | |||
| Resistant Drug | Topscience | |||
| Molecule Alteration | Expressiom | Down-regulation |
||
| Experimental Note | Revealed Based on the Cell Line Data | |||
| In Vitro Model | Mycobacterium tuberculosis | 1773 | ||
| Experiment for Drug Resistance |
MIC assay | |||
| Mechanism Description | These results support the model that the roles of OmpA as a porin protein overexpressing in mycobacteria can increase the hydrophilic ability of the cell wall which can facilitate the streptomycin uptakes and increase the mycobacteria's sensitivity to aminoglycosides. | |||
References
If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Yu.
